title: A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.
abstract: BACKGROUND
  Personalized therapy considering clinical and genetic patient characteristics will further improve breast cancer survival. Two widely used treatments, chemotherapy and radiotherapy, can induce oxidative DNA damage and, if not repaired, cell death. Since base excision repair (BER) activity is specific for oxidative DNA damage, we hypothesized that germline genetic variation in this pathway will affect breast cancer-specific survival depending on treatment.
  
  
  METHODS
  We assessed in 1,408 postmenopausal breast cancer patients from the German MARIE study whether cancer specific survival after adjuvant chemotherapy, anthracycline chemotherapy, and radiotherapy is modulated by 127 Single Nucleotide Polymorphisms (SNPs) in 21 BER genes. For SNPs with interaction terms showing p<0.1 (likelihood ratio test) using multivariable Cox proportional hazard analyses, replication in 6,392 patients from nine studies of the Breast Cancer Association Consortium (BCAC) was performed.
  
  
  RESULTS
  rs878156 in PARP2 showed a differential effect by chemotherapy (p=0.093) and was replicated in BCAC studies (p=0.009; combined analysis p=0.002). Compared to non-carriers, carriers of the variant G allele (minor allele frequency=0.07) showed better survival after chemotherapy (combined allelic hazard ratio (HR)=0.75, 95% 0.53-1.07) and poorer survival when not treated with chemotherapy (HR=1.42, 95% 1.08-1.85). A similar effect modification by rs878156 was observed for anthracycline-based chemotherapy in both MARIE and BCAC, with improved survival in carriers (combined allelic HR=0.73, 95% CI 0.40-1.32). None of the SNPs showed significant differential effects by radiotherapy.
  
  
  CONCLUSIONS
  Our data suggest for the first time that a SNP in PARP2, rs878156, may together with other genetic variants modulate cancer specific survival in breast cancer patients depending on chemotherapy. These germline SNPs could contribute towards the design of predictive tests for breast cancer patients.
authors.affiliation: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. p.seibold@dkfz.de.
authors.forename: Petra
authors.initials: P
authors.lastname: Seibold
authors.affiliation: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69124, Heidelberg, Germany. p.schmezer@dkfz.de.
authors.forename: Peter
authors.initials: P
authors.lastname: Schmezer
authors.affiliation: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. s.behrens@dkfz.de.
authors.forename: Sabine
authors.initials: S
authors.lastname: Behrens
authors.affiliation: Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK. km533@medschl.cam.ac.uk.
authors.forename: Kyriaki
authors.initials: K
authors.lastname: Michailidou
authors.affiliation: Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK. mkh39@medschl.cam.ac.uk.
authors.forename: Manjeet K
authors.initials: MK
authors.lastname: Bolla
authors.affiliation: Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK. qw232@medschl.cam.ac.uk.
authors.forename: Qin
authors.initials: Q
authors.lastname: Wang
authors.affiliation: Department of Cancer Epidemiology/Clinical Cancer Registry, University Cancer Center Hamburg (UCCH), Hamburg, Germany. flesch-janys@uke.de.|Department of Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. flesch-janys@uke.de.
authors.forename: Dieter
authors.initials: D
authors.lastname: Flesch-Janys
authors.affiliation: Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. Heli.Nevanlinna@hus.fi.
authors.forename: Heli
authors.initials: H
authors.lastname: Nevanlinna
authors.affiliation: Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. rainer.fagerholm@helsinki.fi.
authors.forename: Rainer
authors.initials: R
authors.lastname: Fagerholm
authors.affiliation: Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. kristiina.aittomaki@hus.fi.
authors.forename: Kristiina
authors.initials: K
authors.lastname: Aittomäki
authors.affiliation: Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. carl.blomqvist@helsinki.fi.
authors.forename: Carl
authors.initials: C
authors.lastname: Blomqvist
authors.affiliation: Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden. Sara.Margolin@karolinska.se.
authors.forename: Sara
authors.initials: S
authors.lastname: Margolin
authors.affiliation: School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. arto.mannermaa@uef.fi.|Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. arto.mannermaa@uef.fi.|Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. arto.mannermaa@uef.fi.
authors.forename: Arto
authors.initials: A
authors.lastname: Mannermaa
authors.affiliation: School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. vesa.kataja@ksshp.fi.|Central Finland Health Care District, Jyväskylä Central Hospital, Jyväskylä, Finland. vesa.kataja@ksshp.fi.
authors.forename: Vesa
authors.initials: V
authors.lastname: Kataja
authors.affiliation: School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. veli-matti.kosma@uef.fi.|Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. veli-matti.kosma@uef.fi.|Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. veli-matti.kosma@uef.fi.
authors.forename: Veli-Matti
authors.initials: VM
authors.lastname: Kosma
authors.affiliation: School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. jaana.hartikainen@uef.fi.|Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. jaana.hartikainen@uef.fi.|Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. jaana.hartikainen@uef.fi.
authors.forename: Jaana M
authors.initials: JM
authors.lastname: Hartikainen
authors.affiliation: Vesalius Research Center (VRC), VIB, Leuven, Belgium. Diether.Lambrechts@med.kuleuven.be.|Department of Oncology, Laboratory for Translational Genetics, University of Leuven, Leuven, Belgium. Diether.Lambrechts@med.kuleuven.be.
authors.forename: Diether
authors.initials: D
authors.lastname: Lambrechts
authors.affiliation: Department of General Medical Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, Belgium. Hans.Wildiers@uzleuven.be.
authors.forename: Hans
authors.initials: H
authors.lastname: Wildiers
authors.affiliation: Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. v.i.kristensen@medisin.uio.no.|Institute of Clinical Medicine, K.G. Jebsen Center for Breast Cancer Research, Faculty of Medicine, University of Oslo (UiO), Oslo, Norway. v.i.kristensen@medisin.uio.no.|Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital, University of Oslo (UiO), Oslo, Norway. v.i.kristensen@medisin.uio.no.
authors.forename: Vessela
authors.initials: V
authors.lastname: Kristensen
authors.affiliation: Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. greal@rr-research.no.
authors.forename: Grethe Grenaker
authors.initials: GG
authors.lastname: Alnæs
authors.affiliation: Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. silje.nord@rr-research.no.
authors.forename: Silje
authors.initials: S
authors.lastname: Nord
authors.affiliation: Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. a.l.borresen-dale@medisin.uio.no.|Institute of Clinical Medicine, K.G. Jebsen Center for Breast Cancer Research, Faculty of Medicine, University of Oslo (UiO), Oslo, Norway. a.l.borresen-dale@medisin.uio.no.
authors.forename: Anne-Lise
authors.initials: AL
authors.lastname: Borresen-Dale
authors.affiliation: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. m.hooning@erasmusmc.nl.
authors.forename: Maartje J
authors.initials: MJ
authors.lastname: Hooning
authors.affiliation: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. a.hollestelle@erasmusmc.nl.
authors.forename: Antoinette
authors.initials: A
authors.lastname: Hollestelle
authors.affiliation: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. a.jager@erasmusmc.nl.
authors.forename: Agnes
authors.initials: A
authors.lastname: Jager
authors.affiliation: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. c.seynaeve@erasmusmc.nl.
authors.forename: Caroline
authors.initials: C
authors.lastname: Seynaeve
authors.affiliation: Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore. jingmei@gmail.com.
authors.forename: Jingmei
authors.initials: J
authors.lastname: Li
authors.affiliation: Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore. liuj3@gis.a-star.edu.sg.
authors.forename: Jianjun
authors.initials: J
authors.lastname: Liu
authors.affiliation: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Keith.Humphreys@ki.se.
authors.forename: Keith
authors.initials: K
authors.lastname: Humphreys
authors.affiliation: Department of Oncology, Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK. amd24@medschl.cam.ac.uk.
authors.forename: Alison M
authors.initials: AM
authors.lastname: Dunning
authors.affiliation: Department of Oncology, Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK. vr264@medschl.cam.ac.uk.
authors.forename: Valerie
authors.initials: V
authors.lastname: Rhenius
authors.affiliation: Department of Oncology, Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK. ms483@medschl.cam.ac.uk.
authors.forename: Mitul
authors.initials: M
authors.lastname: Shah
authors.affiliation: Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. m.kabisch@dkfz.de.
authors.forename: Maria
authors.initials: M
authors.lastname: Kabisch
authors.affiliation: Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. dianatlopez@yahoo.com.|Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia. dianatlopez@yahoo.com.
authors.forename: Diana
authors.initials: D
authors.lastname: Torres
authors.affiliation: Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany. hu.ulmer@klinikum-mittelbaden.de.
authors.forename: Hans-Ulrich
authors.initials: HU
authors.lastname: Ulmer
authors.affiliation: Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. u.hamann@dkfz-heidelberg.de.
authors.forename: Ute
authors.initials: U
authors.lastname: Hamann
authors.affiliation: Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA. joellen@virginia.edu.
authors.forename: Joellen M
authors.initials: JM
authors.lastname: Schildkraut
authors.affiliation: Department of Oncology, Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, Michigan, USA. purringk@karmanos.org.
authors.forename: Kristen S
authors.initials: KS
authors.lastname: Purrington
authors.affiliation: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Michigan, USA. couch.fergus@mayo.edu.
authors.forename: Fergus J
authors.initials: FJ
authors.lastname: Couch
authors.affiliation: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Per.Hall@ki.se.
authors.forename: Per
authors.initials: P
authors.lastname: Hall
authors.affiliation: Department of Oncology, Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK. pp10001@medschl.cam.ac.uk.
authors.forename: Paul
authors.initials: P
authors.lastname: Pharoah
authors.affiliation: Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK. dfe20@medschl.cam.ac.uk.
authors.forename: Doug F
authors.initials: DF
authors.lastname: Easton
authors.affiliation: Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. mk.schmidt@nki.nl.
authors.forename: Marjanka K
authors.initials: MK
authors.lastname: Schmidt
authors.affiliation: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. j.chang-claude@dkfz.de.
authors.forename: Jenny
authors.initials: J
authors.lastname: Chang-Claude
authors.affiliation: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69124, Heidelberg, Germany. o.popanda@dkfz.de.
authors.forename: Odilia
authors.initials: O
authors.lastname: Popanda
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D017024:Chemotherapy, Adjuvant; D005260:Female; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D011065:Poly(ADP-ribose) Polymerases / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D017698:Postmenopause; D011379:Prognosis; D016016:Proportional Hazards Models; D011878:Radiotherapy
chemical_list: C483041:PARP2 protein, human; D011065:Poly(ADP-ribose) Polymerases